Spondyloarthropathies News

ORLANDO, Fla. — At the Rheumatology Nurses Annual Conference, Iris Zink, MSN, RN, ANP-BC, RN-BC, spoke about inflammation in patients with rheumatic diseases and how one can control it naturally. She said it is important for rheumatology health care providers to educate patients on the importance of diet, exercise, movement, meditation, acupuncture, sleep and limiting stress.

The FDA Arthritis Advisory Committee voted 10-1 today for recommending approval of the supplemental new drug application for tofacitinib in the treatment of adult patients with active psoriatic arthritis.

Harvard S, et al. J Rheumatol. 2017;doi:https://doi.org/10.3899/jrheum.161399

Recently published results showed older adults with arthritis had a lower health-related quality of life, especially among those with at least one other common chronic condition.

With each passing year, big data has taken on a larger role in medicine and more specifically, in rheumatology.

Let me introduce this cautiously entitled Editorial by first expressing how pleased we are to have engaged such a talented and productive group of experts on the use of “big data” in rheumatology. I am wholeheartedly enthusiastic about what we have already reaped from big data and firmly believe the greatest potential for gain in terms of research and care lie ahead.

Novartis has reported positive 5-year efficacy and safety results for Cosentyx from a phase 3 long-term extension study in patients with moderate-to-severe plaque psoriasis.

Among patients with axial spondyloarthritis, five-year sacroiliac joint radiographic progression was limited, according to a recently published study.

Researchers have published a 2017 update of treatments to target for patients with axial spondyloarthritis, peripheral spondyloarthritis and psoriatic arthritis.